Beam Therapeutics (BEAM) Debt Ratio (2019 - 2026)

Beam Therapeutics (BEAM) has 8 years of Debt Ratio data on file, last reported at 0.07 in Q1 2026.

• Debt Ratio for Q1 2026 came in at 0.07, up 1907.79% year-over-year; the trailing twelve-month figure through Mar 2026 was 0.07 (up 1907.79% YoY), and the FY2025 annual result was 0.01, down 31.69% from the prior year.
• Debt Ratio advanced to 0.07 in Q1 2026 per BEAM's latest filing, from 0.01 in the prior quarter.
• Over five years, Debt Ratio peaked at 0.07 in Q1 2026 and troughed at 0.0 in Q2 2025.
• A 5-year average of 0.01 and a median of 0.01 in 2024 frame the typical range for Debt Ratio.
• The sharpest annual moves came in 2022 and 2026: Debt Ratio slumped 87.91% in 2022, then jumped 1907.79% in 2026.
• A 5-year view of Debt Ratio shows it stood at 0.01 in 2022, then tumbled by 45.75% to 0.01 in 2023, then advanced by 2.85% to 0.01 in 2024, then plunged by 31.69% to 0.01 in 2025, then jumped by 1269.09% to 0.07 in 2026.
• Business Quant data shows BEAM's Debt Ratio at 0.07 in Q1 2026, 0.01 in Q4 2025, and 0.0 in Q3 2025.